[1] Lewis C et al. Abstract S44.006, Sitzung S44: MS Risk Factors, Susceptibility, Diagnosis, and Cognitive Impairment am 26. April 2018. 70th AAN Annual Meeting, Los Angeles, 21.-27.04.2018
[2] De Moor C et al. Abstract S44.007, Sitzung S44: MS Risk Factors, Susceptibility, Diagnosis, and Cognitive Impairment am 26. April 2018. 70th AAN Annual Meeting, Los Angeles, 21.-27.04.2018
[3] Cohan S et al. Abstract S44.005, Sitzung S44: MS Risk Factors, Susceptibility, Diagnosis, and Cognitive Impairment am 26. April 2018. 70th AAN Annual Meeting, Los Angeles, 21.-27.04.2018
[4] Benedict RHB et al. 2017, Mult Scler 2017; 23: 721-733
[5] Cree B et al. Abstract S8.005, Sitzung S8: Progressive MS Therapies and Age-Dependent Factors in MS Therapy am 22. April 2018, 70th AAN Annual Meeting, Los Angeles, 21.-27.04.2018
[6] Benedict RHB et al. Abstract S44.004, Sitzung S44: MS Risk Factors, Susceptibility, Diagnosis, and Cognitive Impairment am 26. April 2018. 70th AAN Annual Meeting, Los Angeles, 21.-27.04.2018